Refolding of recombinant proteins

Expression of recombinant proteins as inclusion bodies in bacteria is one of the most efficient ways to produce cloned proteins, as long as the inclusion body protein can be successfully refolded. Aggregation is the leading cause of decreased refolding yields. Developments during the past year have advanced our understanding of the mechanism of aggregation in in vitro protein folding. New additives to prevent aggregation have been added to a growing list. A wealth of literature on the role of chaperones and foldases in in vivo protein folding has triggered the development of new additives and processes that mimic chaperone activity in vitro.

[1]  A. Negro,et al.  Recombinant human TIMP-3 from Escherichia coli: synthesis, refolding, physico-chemical and functional insights. , 1997, Protein engineering.

[2]  R. Rudolph,et al.  Improved Refolding of a Matrix‐Bound Fusion Protein , 1996 .

[3]  M. Ladisch,et al.  Chromatography for Rapid Buffer Exchange and Refolding of Secretory Leukocyte Protease Inhibitor , 1996, Biotechnology progress.

[4]  R. Rudolph,et al.  Renaturation, Purification and Characterization of Recombinant Fab-Fragments Produced in Escherichia coli , 1991, Bio/Technology.

[5]  A. Plückthun,et al.  Engineered turns of a recombinant antibody improve its in vivo folding. , 1995, Protein engineering.

[6]  D. I. Wang,et al.  Polymerization mechanism of polypeptide chain aggregation. , 1997, Biotechnology and bioengineering.

[7]  R. Rudolph,et al.  Improved Refolding of an Immobilized Fusion Protein , 1996, Nature Biotechnology.

[8]  S. Anderson,et al.  Production of correctly folded recombinant [13C, 15N]-enriched guinea pig [Val90]-alpha-lactalbumin. , 1997, Protein engineering.

[9]  A. Fersht,et al.  Refolding chromatography with immobilized mini-chaperones. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  T. Ueda,et al.  Effect of additives on the renaturation of reduced lysozyme in the presence of 4 M urea. , 1996, Protein engineering.

[11]  Daniel I. C. Wang,et al.  Specific aggregation of partially folded polypeptide chains: The molecular basis of inclusion body composition , 1996, Nature Biotechnology.

[12]  J. Chaudhuri,et al.  Protein refolding at high concentration using size‐exclusion chromatography , 1996, Biotechnology and bioengineering.

[13]  D. Hevehan,et al.  Oxidative Renaturation of Hen Egg‐White Lysozyme. Folding vs Aggregation , 1998, Biotechnology progress.

[14]  K. Weisgraber,et al.  Human Low Density Lipoprotein Receptor Fragment , 1997, The Journal of Biological Chemistry.

[15]  S. Gellman,et al.  Artificial chaperone-assisted refolding of denatured-reduced lysozyme: modulation of the competition between renaturation and aggregation. , 1996, Biochemistry.

[16]  R. Jaenicke,et al.  A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme. , 1991, Biochemistry.

[17]  B. Kelley,et al.  Effect of Inclusion Body Contaminants on the Oxidative Renaturation of Hen Egg White Lysozyme , 1997, Biotechnology progress.

[18]  R. Rudolph,et al.  In vitro folding of inclusion body proteins , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  J. Ahn,et al.  Investigation of refolding condition for Pseudomonas fluorescens lipase by response surface methodology. , 1997, Journal of biotechnology.

[20]  F. Jähnig,et al.  Pathway of detergent-mediated and peptide ligand-mediated refolding of heterodimeric class II major histocompatibility complex (MHC) molecules. , 1997, European journal of biochemistry.

[21]  J. Yon.  The specificity of protein aggregation , 1996, Nature Biotechnology.

[22]  M. Brandon,et al.  Comparing the refolding and reoxidation of recombinant porcine growth hormone from a urea denatured state and from Escherichia coli inclusion bodies. , 1995, Biochemistry.

[23]  E. De Bernardez Clark,et al.  Oxidative renaturation of hen egg-white lysozyme in polyethylene glycol-salt aqueous two-phase systems. , 1999, Biotechnology and bioengineering.

[24]  D. J. Cowley,et al.  Expression, purification and characterization of recombinant human proinsulin , 1997, FEBS letters.

[25]  D. Segal,et al.  Correct disulfide pairing and efficient refolding of detergent-solubilized single-chain Fv proteins from bacterial inclusion bodies. , 1995, Molecular immunology.

[26]  J. Chaudhuri,et al.  Studies of the hydrodynamic volume changes that occur during refolding of lysozyme using size-exclusion chromatography. , 1997, Journal of chromatography. A.

[27]  T. Ueda,et al.  Effective renaturation of denatured and reduced immunoglobulin G in vitro without assistance of chaperone. , 1996, Protein engineering.

[28]  F. Baneyx,et al.  Molecular chaperones, folding catalysts, and the recovery of active recombinant proteins fromE. coli , 1997, Applied biochemistry and biotechnology.

[29]  O. Ptitsyn,et al.  Kinetic and equilibrium folding intermediates. , 1995, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[30]  D. Wetlaufer,et al.  Control of aggregation in protein refolding: The temperature‐leap tactic , 1996, Protein science : a publication of the Protein Society.

[31]  C. Vial,et al.  Refolding of SDS- and thermally denatured MM-creatine kinase using cyclodextrins. , 1996, Biochemical and biophysical research communications.

[32]  D. Wetlaufer,et al.  Control of aggregation in protein refolding: A variety of surfactants promote renaturation of carbonic anhydrase II , 1995, Protein science : a publication of the Protein Society.

[33]  D. Hevehan,et al.  Oxidative renaturation of lysozyme at high concentrations. , 1997, Biotechnology and bioengineering.

[34]  L. Nieba,et al.  Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment. , 1997, Protein engineering.

[35]  T. Randolph,et al.  Molten Globule Intermediate of Recombinant Human Growth Hormone: Stabilization with Surfactants , 1996, Biotechnology progress.

[36]  T. Creighton.  How important is the molten globule for correct protein folding? , 1997, Trends in biochemical sciences.

[37]  A. Clarke,et al.  Protein folding pathways and intermediates , 1997 .

[38]  T. Creighton,et al.  Folding proteins , 1990, Nature.

[39]  J. King.  Refolding with a piece of the ring , 1997, Nature Biotechnology.

[40]  Goldberg,et al.  Non-detergent sulphobetaines: a new class of molecules that facilitate in vitro protein renaturation. , 1995, Folding & design.

[41]  R. Burgess,et al.  Purification of overproduced Escherichia coli RNA polymerase sigma factors by solubilizing inclusion bodies and refolding from Sarkosyl. , 1996, Methods in enzymology.

[42]  S. Gellman,et al.  Artificial Chaperone-assisted Refolding of Carbonic Anhydrase B , 1996, The Journal of Biological Chemistry.